Legacy Advisory Services, LLC Merck & Co., Inc. Transaction History

Legacy Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$77.6 - $87.37 $276,876 - $311,736	-3,568 Closed	0 $0
Q1 2025 May 19, 2025	BUY	$83.01 - $101.02 $373,046 - $453,983	4,494 New	4,494 $403 Million
Q3 2024 Oct 17, 2025	BUY	$111.15 - $128.97 $396,583 - $460,164	3,568 New	3,568 $405 Million
Q2 2024 Oct 30, 2025	BUY	$123.8 - $132.96 $441,718 - $474,401	3,568 New	3,568 $442 Million
Q1 2024 Oct 17, 2025	SELL	$113.24 - $131.95 $6,794 - $7,916	-60 Reduced 1.65%	3,568 $471 Million

Q4 2023 Oct 17, 2025	BUY	$100.18 - $109.02 $363,453 - $395,524	3,628 New	3,628 $396 Million

3,875

1.9B

30.1M

27.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Legacy Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Advisory Services, LLC with notifications on news.